| Literature DB >> 33194925 |
Ming-Chun Yang1,2,3, Hsien-Kuan Liu1,3, Hsuan-Yin Wu3,4, Shu-Leei Tey1,2, Yung-Ning Yang1,2,3, Chien-Yi Wu1,2, Jiunn-Ren Wu1.
Abstract
Background: Patent ductus arteriosus (PDA) with a bidirectional shunt reflects critical clinical conditions. The operability of PDA with a bidirectional shunt in pre-term infants is still not clearly clarified. This study aimed to investigate the feasibility and the outcomes of PDA ligation in pre-term infants with a bidirectional shunt PDA.Entities:
Keywords: bidirectional shunt; contraindication; outcomes; patent ductus arteriosus ligation; pre-term infant; pulmonary hypertension; surgery
Year: 2020 PMID: 33194925 PMCID: PMC7649389 DOI: 10.3389/fped.2020.591441
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.418
Figure 1(A) represented a continuous left-to-right shunt of a PDA, which was detected by pulse-wave Doppler. At the end-diastolic phase, there was a persistent left-to-right shunt; (B,C) represented a bidirectional shunt of a PDA. At the end-diastolic phase, the shunting directions were transient right-to-left; (D) represented a right-to-left shunt. There was rare left-to-right shunt either at the systolic or diastolic phase.
Demographic characteristics and pre-operative conditions.
| Number | 18 | 19 | |
| Gestational age (week-old) | 29.1 ± 0.8 | 30.9 ± 1.2 | 0.22 |
| Birth body weight (gram) | 1329 ± 201 | 1452 ± 187 | 0.66 |
| Vaginal delivery | 10 (55.6%) | 5 (26.3%) | 0.09 |
| Male | 9 (50%) | 11 (57.9%) | 0.63 |
| Antenatal corticosteroid | 7 (38.9%) | 3 (15.8%) | 0.11 |
| Age at surgery (day-old) | 20.4 ± 8.2 | 13.2 ± 5.5 | 0.22 |
| Age at surgery (PMA, week-old) | 32.0 ± 1.3 | 32.8 ± 1.5 | 0.68 |
| Body weight at surgery (gram) | 1544 ± 264 | 1585 ± 216 | 0.90 |
| Severe IVH | 2 (11.1%) | 4 (21.1%) | 0.66 |
| Periventricular leukomalacia | 1 (5.6%) | 1 (5.3%) | 1.00 |
| Meconium ileus | 1 (5.6%) | 0 (0%) | 0.47 |
| NEC | 1 (5.6%) | 0 (0%) | 0.47 |
| Pulmonary hemorrhage | 5 (27.8%) | 9 (47.4%) | 0.31 |
| Acute kidney injury | 10 (55.6%) | 11 (57.9%) | 0.67 |
| Non-invasive ventilator or no support | 9 (50%) | 2 (10.5%) | <0.01* |
| Invasive ventilator | 9 (50%) | 17 (89.5%) | <0.01* |
| Conventional ventilator | 8 (44.4%) | 9 (47.4%) | 0.09 |
| HFOV | 1 (5.6%) | 8 (42.1%) | 0.012* |
| Inhaled nitric oxide | 0 | 2 (10.5%) | |
| Oxygen index | 4.7 ± 2.2 | 9.3 ± 2.7 | 0.02* |
| LA/Ao ratio | 1.73 ± 0.07 | 1.73 ± 0.08 | 0.97 |
| PDA size/BW (mm/kg) | 2.1 ± 0.2 | 2.4 ± 0.2 | 0.33 |
| Cardiothoracic ratio on radiograph | 0.60 ± 0.05 | 0.65 ± 0.08 | 0.74 |
| Serum creatinine before PDA closure (mg/dL) | 1.1 ± 0.6 | 1.4 ± 1.0 | 0.21 |
| Prior ibuprofen/acetaminophen treatment | 7 (38.9%) | 3 (15.8%) | 0.11 |
HFOV, high frequency oscillatory ventilator; IVH, grade 3 or 4 intraventricular hemorrhage; LA/Ao ratio, left atrium-to-aorta ratio; NEC, stage 2 or 3 necrotizing enterocolitis; PMA, post-menstrual age; * represented statistically significant, p < 0.05.
Perioperative vital signs of the patients receiving PDA ligation.
| Pre-op body temperature (°C) | 36.7 ± 0.1 | 36.4 ± 0.2 | 0.23 |
| Pre-op heart rate (bpm) | 162 ± 2 | 165 ± 3 | 0.58 |
| Tachycardia > 160 bpm | 12 | 13 | 0.91 |
| Use of dopamine | 5 | 12 | 0.03 |
| Systolic blood pressure | 64 ± 3 | 63 ± 3 | 0.91 |
| Diastolic blood pressure | 36 ± 2 | 35 ± 3 | 0.80 |
| Mean blood pressure | 45 ± 2 | 42 ± 2 | 0.83 |
| Estimated PASP (mmHg) | 41 ± 2 | 58 ± 3 | <0.001 |
| Post-op body temperature (°C) | 36.6 ± 0.1 | 36.6 ± 0.1 | 0.74 |
| Post-op heart rate (bpm) | 165 ± 3 | 166 ± 4 | 0.75 |
| Systolic blood pressure | 66 ± 4 | 67 ± 5 | 0.88 |
| Diastolic blood pressure | 42 ± 3 | 44 ± 4 | 1.00 |
| Mean blood pressure | 50 ± 3 | 50 ± 4 | 0.95 |
Bpm, beats per minute; PASP, pulmonary arterial systolic pressure;
represented statistically significant, p < 0.05.
Primary outcome–immediate complications after PDA ligation.
| PDA bleeding during surgery | 0 (0%) | 4 (21.1%) | 0.04 |
| Intraoperative desaturation | 1 (5.9%) | 3 (15.8%) | 0.32 |
| Pneumothorax | 1 (5.9%) | 2 (10.5%) | 0.62 |
| Hemothorax | 0 (0%) | 1 (5.3%) | 0.34 |
| Vocal cord paralysis | 1 (5.9%) | 0 (0%) | 0.28 |
| Phrenic nerve palsy | 2 (11.8%) | 0 (0%) | 0.12 |
| Immediate surgical mortality | 0 (0%) | 0 (0%) | NS |
NS, non-significant;
represented statistically significant, p < 0.05.
Secondary outcomes–late adverse outcomes after PDA ligation.
| Neurological complications | |||
| Post-op severe IVH | 6 (33.3%) | 5 (26.3%) | 0.72 |
| IVH progression | 4 (22.2%) | 1 (5.3%) | 0.15 |
| Post-op PVL | 6 (33.3%) | 4 (21.1%) | 0.46 |
| Progression to PVL | 6 (33.3%) | 1 (5.3%) | 0.04 |
| Hydrocephalus | 2 (11.1%) | 3 (15.8%) | 0.63 |
| Post-op NEC | 0 | 2 (10.5%) | 0.16 |
| Bronchopulmonary dysplasia | |||
| Overall | 16 (88.9%) | 9 (47.4%) | 0.054 |
| Mild | 3 (16.7%) | 0 | 0.10 |
| Moderate | 1 (5.6%) | 0 | 0.36 |
| Severe | 12 (66.6%) | 9 (47.4%) | 0.71 |
| Early mortality | 0 | 4 (21.1%) | 0.04 |
| Overall Mortality | 0 | 5 (26.3%) | 0.02 |
| Composite outcomes | |||
| Early mortality or progression to PVL | 6 (33.3%) | 7 (36.8%) | 0.82 |
| Early mortality or post-op NEC | 0 | 5 (26.3%) | 0.02 |
| Early mortality or BPD | 16 (88.9%) | 13 (68.4%) | 0.13 |
| Death after PDA ligation (days) | NA | 29 ± 19 | NA |
BPD, Bronchopulmonary dysplasia; IVH, intraventricular hemorrhage; NEC, Necrotizing enterocolitis; PVL, Periventricular leukomalacia; NA, not applicable;
represented statistically significant, p < 0.05.
Figure 2Cumulative survival after PDA ligation. The solid line is the left-to-right group. The dotted line is the bidirectional group. The Log-rank test revealed a significant difference in survival, p = 0.02.